Brief: Acer Therapeutics Announces Presentation Of HCP Urea Cycle Disorder Treatment Preference Data
15/03/2023 12:47
March 15 (Reuters) - Acer Therapeutics Inc ACER.O :
* ACER THERAPEUTICS ANNOUNCES PRESENTATION OF HCP UREA CYCLE
DISORDER TREATMENT PREFERENCE DATA AT THE SOCIETY FOR INHERITED
METABOLIC DISORDERS ANNUAL MEETING AND PROVIDES OLPRUVA™ PROGRAM
UPDATE
* ACER THERAPEUTICS INC - OLPRUVA DRUG AVAILABILITY
ANTICIPATED
BY EARLY JULY 2023
Source text for Eikon: ID:nGNX89fHRz
Further company coverage: ACER.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acer Therapeutics
See all newsBrief: Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Acer Therapeutics Shareholders Vote "For" The Proposed Merger And Related Proposals
U.S. STOCKS ON THE MOVE-UGI, SkyWest, Sage Therapeutics
Acer Therapeutics surges on Zevra buyout deal
Brief: Zevra Therapeutics To Acquire Acer Therapeutics, Expanding Its Rare Disease Portfolio And Adding Commercial Product
Swiss stocks - Factors to watch on August 31